ARQT logo

ARQT
Arcutis Biotherapeutics Inc

2,470
Mkt Cap
$2.63B
Volume
1.36M
52W High
$31.77
52W Low
$11.86
PE Ratio
-151.68
ARQT Fundamentals
Price
$21.22
Prev Close
$22.38
Open
$22.23
50D MA
$25.13
Beta
1.38
Avg. Volume
1.41M
EPS (Annual)
-$0.1269
P/B
13.81
Rev/Employee
$1.06M
$3,587.81
Loading...
Loading...
News
all
press releases
Nordea Investment Management AB Acquires New Holdings in Arcutis Biotherapeutics, Inc. $ARQT
Nordea Investment Management AB bought a new position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) during the 4th quarter, according to its most recent 13F filing with the...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Silverleafe Capital Partners LLC Increases Stock Holdings in Arcutis Biotherapeutics, Inc. $ARQT
Silverleafe Capital Partners LLC increased its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 278.8% in the fourth quarter, according to its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
Ally Bridge Group NY LLC Invests $4.40 Million in Arcutis Biotherapeutics, Inc. $ARQT
Ally Bridge Group NY LLC bought a new position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·14d ago
News Placeholder
GW&K Investment Management LLC Sells 206,391 Shares of Arcutis Biotherapeutics, Inc. $ARQT
GW&K Investment Management LLC decreased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 15.0% during the third quarter, according to its most recent filing...
MarketBeat·22d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) CFO Latha Vairavan Sells 2,853 Shares
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) CFO Latha Vairavan sold 2,853 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average...
MarketBeat·25d ago
News Placeholder
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 3,687 Shares
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Larry Todd Edwards sold 3,687 shares of Arcutis Biotherapeutics stock in a transaction dated Monday, March 2nd. The shares were...
MarketBeat·25d ago
News Placeholder
Masaru Matsuda Sells 3,325 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Masaru Matsuda sold 3,325 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The stock was sold...
MarketBeat·25d ago
News Placeholder
Patrick Burnett Sells 6,287 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Patrick Burnett sold 6,287 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an...
MarketBeat·25d ago
News Placeholder
Masaru Matsuda Sells 8,733 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Masaru Matsuda sold 8,733 shares of the firm's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at...
MarketBeat·25d ago
News Placeholder
Insider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 37,349 Shares of Stock
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Get Free Report) insider Todd Watanabe sold 37,349 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an...
MarketBeat·25d ago
<
1
2
...
>

Latest ARQT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.